Anacor Pharmaceuticals Gets Loan Funding
Palo Alto-based Anacor Pharmaceuticals, a developer of small-molecule therapeutics derived from a boron chemistry platform, has entered into a new, $45.0M loan agreement, the company said this week. The company said the loan comes from Hercules Technology Growth Capital, and will be distributed in three tranches. The firm said $22.6M of the first $30M tranche will go towards paying off a remaining loan agreement, with the remainder going to New Drug Application (NDA) activity. Anacor is publicly traded on the NASDAQ as ANAC.
posted on Thursday, June 13, 2013
Related companies:
Anacor Pharmaceuticals
Related stories:
> Anacor Pharmaceuticals Takes $50M More
> Anacor Pharmaceuticals Files For IPO
> Anacor Pharmaceuticals Files For IPO
> AcelRX Gains $20M In Loan Funding
> OCZ Technology Lands $30M Venture Loan
silicontap.com Home